Publication

Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries

Journal Paper/Review - Jun 7, 2010

Units
Contact

Citation
Tettenborn B, Putzki N, Yaldizli O, Mäurer M, Cursiefen S, Kuckert S, Maschke M, Limmroth V. Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries. Eur J Neurol 2010; 17 (1):31-7.
Type
Journal Paper/Review (Deutsch)
Journal
Eur J Neurol 2010; 17 (1)
Publication Date
Jun 7, 2010
Pages
31-7
Brief description/objective